A Randomized, Double-Blind, Vehicle-Controlled Study of the Safety and Efficacy of WC3011 in the Treatment of Symptoms of Vulvovaginal Atrophy in Postmenopausal Women.

Trial Profile

A Randomized, Double-Blind, Vehicle-Controlled Study of the Safety and Efficacy of WC3011 in the Treatment of Symptoms of Vulvovaginal Atrophy in Postmenopausal Women.

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Apr 2012

At a glance

  • Drugs Estradiol (Primary)
  • Indications Atrophic vaginitis; Menopausal syndrome
  • Focus Registrational; Therapeutic Use
  • Acronyms VENUS
  • Most Recent Events

    • 24 Apr 2012 Actual patient number changed from 684 to 722 as reported by ClinicalTrials.gov (Parent: NCT01400776).
    • 24 Apr 2012 Actual end date (Feb 2012) added as reported by ClinicalTrials.gov (Parent: NCT01400776).
    • 24 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov. (Parent: NCT01400776)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top